18594291. COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA simplified abstract (SANOFI)
Contents
COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA
Organization Name
Inventor(s)
Nadège Arnaud Barbe of Paris (FR)
Leah Cole of Cambridge MA (US)
Andreas Karlsson of Paris (FR)
Violette Sanchez of Paris (FR)
Timothy Tibbitts of Cambridge MA (US)
COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA - A simplified explanation of the abstract
This abstract first appeared for US patent application 18594291 titled 'COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA
The invention described in the abstract relates to compositions, such as vaccine compositions, that can be used to immunize against infections. These compositions contain specific antigens and antigen combinations that can be used to immunize against specific pathogens, either in the form of nucleic acids encoding antigenic proteins or in the form of recombinant protein antigens.
- The compositions described in the patent application can be used to develop vaccines that target specific pathogens.
- These vaccines can be formulated using nucleic acids encoding antigenic proteins or recombinant protein antigens.
- The technology aims to provide effective immunization against infections by targeting specific antigens.
- By using specific antigens and antigen combinations, the vaccines can be tailored to address the immunization needs for different pathogens.
- The innovation in this patent application lies in the development of compositions that can effectively immunize against specific infections.
Potential Applications: The technology described in the patent application can be applied in the development of vaccines for various infectious diseases. These compositions can be used in the prevention and control of outbreaks caused by specific pathogens. The technology can be utilized in the field of public health to enhance immunization strategies against targeted infections.
Problems Solved: The technology addresses the need for specific vaccines that target particular pathogens. It provides a solution for developing effective immunization strategies against infections. The compositions offer a tailored approach to immunization by focusing on specific antigens.
Benefits: The technology can lead to the development of more targeted and effective vaccines. It has the potential to improve immunization outcomes and reduce the spread of infectious diseases. The compositions offer a promising solution for enhancing public health efforts against specific pathogens.
Commercial Applications: Title: "Innovative Vaccine Compositions for Targeted Immunization" The technology can be commercialized by pharmaceutical companies for the development and production of specific vaccines. It has market implications in the healthcare industry, particularly in the field of infectious disease prevention and control.
Questions about the technology: 1. How do the compositions described in the patent application differ from traditional vaccines? The compositions in the patent application focus on specific antigens and antigen combinations to target particular pathogens, offering a more tailored approach to immunization.
2. What potential impact could these innovative vaccine compositions have on public health initiatives? These vaccine compositions have the potential to enhance immunization strategies, improve public health outcomes, and reduce the burden of infectious diseases.
Original Abstract Submitted
This invention relates to compositions (e.g., vaccine compositions) which can be used to immunise against infections. The compositions comprise sp. antigens and antigen combinations which can be used to immunise against sp., used in the form of nucleic acids (e.g., mRNAs) encoding antigenic proteins or in the form of recombinant protein antigens.
